SCHEDULE: Morgan Stanley Boosts Evolent Health Stake to 8.1%

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, reported beneficial ownership of 8.1% of Evolent Health, Inc.'s Class A Common Stock as of December 31, 2025.

Summary

• Morgan Stanley, along with its wholly-owned subsidiary Morgan Stanley Capital Services LLC, reported beneficial ownership of Evolent Health, Inc. Class A Common Stock.
• As of December 31, 2025, Morgan Stanley beneficially owned an aggregate of 9,097,808 shares, representing 8.1% of the Class A Common Stock.
• Morgan Stanley holds shared voting power over 9,083,261 shares and shared dispositive power over 9,097,808 shares.
• Morgan Stanley Capital Services LLC beneficially owned 7,380,233 shares, representing 6.6% of the Class A Common Stock, with shared voting and dispositive power over all these shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Evolent Health, Inc.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant stake by a major institutional investor like Morgan Stanley can be interpreted as a vote of confidence in Evolent Health, Inc.

Positives

• A significant stake by a major institutional investor like Morgan Stanley can signal confidence in Evolent Health, Inc.'s long-term prospects.
• The holding is stated to be in the ordinary course of business, indicating a passive investment rather than an activist intent to influence control.

Risks

• The filing does not detail specific risks related to Evolent Health, Inc.'s operations or financial performance, as it is solely an ownership disclosure.

Future Outlook

This filing does not contain any forward-looking statements or guidance from Evolent Health, Inc. or the reporting persons regarding the issuer's future performance.

Industry Context

StockSavvy.ai notes that increased institutional ownership, particularly from a prominent financial institution like Morgan Stanley, often reflects a growing interest in the healthcare technology sector. This could indicate a positive long-term view on Evolent Health's position within this evolving industry.

Stakeholder Impact

• Shareholders may perceive increased confidence in Evolent Health, Inc. due to the significant institutional investment from Morgan Stanley.
• The market may react positively to the disclosure of a large, passive institutional stake, potentially influencing trading sentiment.

Key Dates

Recommendation

A 'hold' recommendation is appropriate as the filing indicates a substantial, passive institutional investment by Morgan Stanley, suggesting a long-term interest in Evolent Health, Inc. While this is a positive signal of confidence, the filing itself does not provide sufficient fundamental or operational details to warrant a 'buy' or 'sell' recommendation. Investors should consider this ownership alongside other financial and strategic analyses of the company.

Keywords

Evolent Health, Morgan Stanley, Schedule 13G, Institutional Ownership, Class A Common Stock, Beneficial Ownership, Healthcare Technology